Answers are grounded in this paper and cite their sources.
Rho-kinase is a serine/threonine protein kinase that is responsible for maintaining cell shape and adhesion through its action on the cell cytoskeleton. It has an effect on the Rho-A protein, which is responsible for the functioning of the cytoskeleton machinery, by facilitating its transformation between an active conformation bound to Guanosine Triphosphate (GTP) and an inactive one bound to Guanosine Diphosphate (GDP). Other factors, such as guanine nucleotide exchange (GEF), GTPase Abstract Rho-kinase inhibitors promote the proliferation of corneal endothelial cells, increasing intercellular adhesion and suppressing apoptosis. Three cases of patients with low endothelial count, who underwent cataract phacoemulsification plus intraocular lens implantation and who received topical Ripasudil, a Rho kinase inhibitor, one week before and one month during the postoperative period, are described. The first case had 1,691 cells/mm2, the second 1,487 cells/mm2, and the third 1,359 cells/mm2. Following the treatment with Ripasudil in the perioperative period, 6 months after surgery, specular microscopies were performed, obtaining the following results: 1,525 cells/mm2, 1,361 cells/mm2, and 1,215 cells/mm2, respectively, evidencing a loss of endothelial cells between 8.47%. and 10.6%, since this is not so significant despite the background pathologies, it could be postulated that Rho kinase inhibitors have a protective effect on the corneal endothelium.
No takes yet. Share an insight, caveat, or question.
Silva et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: